<DOC>
	<DOCNO>NCT02843321</DOCNO>
	<brief_summary>To assess safety biological efficacy prophylactically administer donor-derived multi-infection specific cytotoxic T lymphocytes ( CTLs ) ( target cytomegalovirus ( CMV ) , Adenovirus ( Adv ) , Epstein Barr virus ( EBV ) , Varicella-Zoster virus ( VZV ) , Influenza ( Flu ) , BK virus ( BKV ) , Aspergillus ( Asp ) ) combine early immunisation Influenza VZV vaccine prevention viral fungal infection follow allogeneic blood marrow stem cell transplantation .</brief_summary>
	<brief_title>Combined Infusion Cytotoxic T-Lymphocytes Vaccination</brief_title>
	<detailed_description>The study analyse safety biological efficacy administer investigational product ( donor-derived T cell stimulate viral fungal antigen express DC combine Flu VZV immunisation ) , prophylaxis viral fungal reactivation and/or infection follow allogeneic blood marrow transplantation . The cell give prophylactically minimum 28 day transplantation follow administration Flu VZV vaccines 24 72 hour later . The AIMS study safety combine CTL infusion vaccination well effect reconstitution infection-specific immunity , viral Aspergillus reactivation infection rate transplantation , viral load , use antiviral antifungal pharmacotherapy specific infection . The investigator also evaluate safety infusion vaccination respect development adverse event within first 12 month post transplant .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients undergo myeloablative nonmyeloablative allogeneic transplantation HLA ( A , B DR ) identical 13 antigen mismatch family unrelated donor . Transplant perform type nonmalignant condition haematological malignancy include limited acute chronic leukaemia , myelodysplasia , non Hodkgins Hodgkin lymphoma myeloma . Recipients peripheral blood bone marrow stem cell . Adequate hepatic renal function ( &lt; 3 x upper limit normal AST ( SGOT ) , ALT ( SGPT ) , &lt; 2 x upper limit normal total bilirubin , serum creatinine ) . Estimated life expectancy least 6 month . Patient ( legal representative ) give informed consent Use antilymphocyte globulin ( ALG , ATG , Campath broad spectrum lymphocyte antibody ) give 4 week immediately prior infusion plan within 4 week infusion . Grade II great graft versus host disease within 1 week prior infusion . Prednisone methylprednisone dose &gt; 1 mg/kg ( equivalent steroid preparation ) administer within 72 hour prior cell infusion . Allergies eggs component Fluvax Varivax vaccine . Privately insured outpatient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>infection</keyword>
</DOC>